Stronger Together: Collaborating with Dermatologists for Better Outcome

EP: 1.Recognizing and Diagnosing Atopic Dermatitis With Confidence

EP: 2.A Practical Guide to Atopic Dermatitis Differential Diagnosis

EP: 3.Quantifying Atopic Dermatitis in Practice: Evaluating Patient Disease Severity

EP: 4.Soothing the Skin: Wellness Practices for Atopic Dermatitis Management

EP: 5.The Topical Toolbox: A Review of Atopic Dermatitis Treatment Options

EP: 6.TCS and TCIs: Benefits, Risks, and Real-World Uses for Atopic Dermatitis

EP: 7.Beyond Steroids: Clinical Trial Results on the Next Generation Agents for Atopic Dermatitis

EP: 8.Tailoring Treatment: Personalizing Topical Therapy for Patients With Atopic Dermatitis

Now Viewing

EP: 9.Stronger Together: Collaborating with Dermatologists for Better Outcome

EP: 10.Real Cases, Key Takeaways: Applying Atopic Dermatitis Insights in Clinical Practice

Video content above is prompted by the following:

Determining appropriate timing for dermatology referral in atopic dermatitis management depends on treatment response despite optimal topical therapy implementation. Patients should be referred when persistent symptoms continue after proper skincare practices, appropriate topical corticosteroid and non-steroidal use, and proactive maintenance treatment. Key referral indicators include ongoing pruritus, significant quality-of-life impacts, and need for systemic therapy discussions beyond primary care comfort levels.

Primary care providers play crucial roles in initial atopic dermatitis management, often representing patients' first healthcare contact. Most mild-to-moderate cases can be effectively managed in primary care settings through comprehensive patient education about proper skincare, irritant avoidance, and proactive treatment strategies. Success requires understanding quality-of-life impacts beyond cosmetic concerns, as untreated atopic dermatitis leads to significant atopic and non-atopic comorbidities affecting sleep, mental health, and overall wellbeing.

Advanced therapeutic options available through dermatology consultation include biologics, JAK inhibitors, traditional immunosuppressants, and phototherapy. Biologics offer targeted cytokine blockade with excellent safety profiles, while JAK inhibitors provide broader intracellular signaling interference with superior efficacy but require careful patient selection due to FDA box warnings. Phototherapy, specifically UVB treatment, remains underutilized despite effectiveness for both in-office and home-based treatment protocols.